Peter Kane, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Wilmington, NCNPI 1447281217
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $52,500 of the $71,542 with a category attached, or 73.4%. Abiomed accounts for 87.3% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2021 at $26,779 and has fallen 87.7% since, to $3,305 in 2025.
Across 187 payments — averaging $382.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$62K
- Edwards Lifesciences$3K
- Kerecis Limited$2K
- Medtronic$2K
- Cvrx, Inc.$1K
- Abbott$471
- plus $1K from 15 others
What the payments were for
- Consulting fees$6001%
- Speaking & faculty fees$52,50073%
- Travel & lodging$10,21714%
- Food & beverage$8,22611%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 69 | $62,448 |
| Edwards Lifesciences | 21 | $3,157 |
| Kerecis Limited | 6 | $1,622 |
| Medtronic(2 entities) | 36 | $1,501 |
| Cvrx, Inc. | 16 | $1,229 |
| Abbott | 4 | $471 |
| Johnson & Johnson | 13 | $450 |
| Atricure, Inc. | 5 | $205 |
| Biomerieux Inc | 1 | $100 |
| Livanova USA, Inc. | 2 | $98 |
| Getinge USA Sales, LLC | 2 | $48 |
| Cook Medical LLC | 3 | $47 |
| Grifols USA, LLC | 1 | $26 |
| Corcym Inc | 1 | $24 |
| Baxter Healthcare | 1 | $19 |
| Artivion, Inc. | 1 | $18 |
| Angiodynamics, Inc. | 1 | $18 |
| Davol Inc. | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| LSI Solutions Inc | 1 | $14 |
| Tricoast Surgical Solutions LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$60,172
- Kerecis SurgiClose$5,203
- EDWARDS INTUITY Elite valve system$2,142
- Kerecis GraftGuide$1,301
- Barostim Neo System$1,080
- Kerecis Omega3 Marigen$1,042
- ENDURANT IIS$270
- Kerecis Omega3 SurgiClose$260
- INSPIRIS RESILIA aortic valve$190
- JOT DX$180
- AVEIR$177
- COREVALVE EVOLUT R$156
- Carpentier-Edwards Physio II Annuloplasty Ring$134
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$123
- ATRICLIP LAA EXCLUSION SYSTEM$123
- SURGICEL NU-KNIT$116
- ECHELON ENDOPATH$116
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$113
- MITRIS RESILIA Mitral Valve$106
How this compares
$71,542 in reported general payments places this provider in the 85th percentile of 132 thoracic surgery (cardiothoracic vascular surgery) providers in North Carolina.
See all thoracic surgery (cardiothoracic vascular surgery) providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other thoracic surgery (cardiothoracic vascular surgery) in Wilmington
- Howard MarksWilmington$11K
- Joseph RubelowskyRaleigh$2.2M
- Matthew HartwigDurham$406K
- Gregory SmaroffNew Bern$205K
- David HarpoleDurham$177K
- Carmelo MilanoLumberton$169K
- Walter ChitwoodGreenville$139K
- Michael MillChapel Hill$137K
- Eric SkipperCharlotte$132K
- Brett StarrHickory$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.